NCT00268632View on ClinicalTrials.gov

"IMPACT Study (Improving Measurements of Persistence on ACtonel Treatment)"

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Primary Completion Date

February 28, 2002

Conditions
Osteoporosis
Interventions
DRUG

risedronate

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

lead

Sanofi

INDUSTRY